EnsoData Accelerates Analysis of Human Health, Improving Diagnostic Accuracy and Saving Hospitals Significant Time and Money
MADISON, WIS. — May 29, 2020 — EnsoData, the company simplifying the process for analyzing how the human body is performing to accurately diagnose health conditions, today announces $9 million Series A financing led by Zetta Venture Partners and Venture Investors. Using artificial intelligence, EnsoData’s technology transforms millions of waveform data points collected from sensors in medical devices and wearables into an easy-to-read printout for more accurate diagnoses.
Waveforms are used in healthcare to diagnose, monitor, and treat patients. Heartbeats on an EKG, eye movements through an EOG, and brain waves through an EEG all output as waveform data, with 1.5 billion waveforms run per year globally across specialties. EnsoData leads the world in reading and understanding these waveforms, starting with sleep.
“Sleep apnea is a condition that plagues nearly one billion people worldwide, and we’re uniquely positioned to address this massive problem,” said Chris Fernandez, CEO of EnsoData. “We know that not everyone has access to quality and affordable treatment, and think that our technology can help bridge that gap. Automating waveform data analysis saves clinicians significant time, and labs and healthcare systems significant money, so they can focus on what really matters — the patients and what’s literally keeping them up at night.”
Why Start with Sleep?
People spend 1/3 of their lives asleep and yet scientists know very little about its impact on overall health and happiness. Sleep apnea, a condition comorbid with obesity, depression, diabetes, hypertension, asthma, and many other diagnoses, affects millions of Americans and costs nearly $200B per year to treat — even as most cases go undiagnosed and/or untreated. By analyzing the waveforms found in sleep studies, EnsoData is able to accurately detect and diagnose sleep apnea and its related conditions — at a drastically reduced cost of both time and money.
“We believe that EnsoData will be a game-changer for the way we diagnose and treat patients,” said Mark Gorenberg, Managing Director at Zetta Venture Partners. “Sleep is just the beginning. Waveform AI may be the lowest cost, most scalable, and most widely available tool for diagnosing patients. It will seriously advance our understanding of health and the human body.”
How It Works
EnsoData is the first artificial intelligence technology approved for sleep disorder diagnosis. By analyzing millions of waveform data points, it quickly finds patterns and events for clinical diagnosis, replacing a workflow that requires hours from clinicians to manually mark volumes of data by hand.
EnsoData partners with top clinicians, health systems, and academic medical centers to improve healthcare outcomes by streamlining data analysis with Waveform AI.
In addition to Zetta Venture Partners and Venture Investors, the round was filled out by a syndicate of institutional investors from across the country, including SleepScore Ventures, Dreamit Ventures, and Necessary Ventures. The Series A participants join seed investors Colle Capital, HealthX Ventures, Sternhill Associates, as well as board of directors members Justin Mortara and Dr. Fred Robertson.
The new capital will be used to launch new AI products in sleep and neurology, grow the company’s world-class team, and expand partnerships with leading sleep clinics, enterprise health centers, academic medical centers, home sleep testing providers, and integrated diagnostic testing facilities.
“Now more than ever, we need to break down barriers to patient care. COVID-19 has disrupted sleep centers and medical facilities across the country, forcing them to shut down or find new ways to reach patients,” said Scott Button, Managing Director of Venture Investors. “EnsoData’s launch marks an optimistic future for getting clinics to build back better, with a more efficient and effective process. We’re thrilled to be a part of this incredible journey to uncovering diagnostics hidden in waveforms — for those suffering from sleep disorders and beyond.”
# # #
ABOUT ENSODATA
EnsoData simplifies the process for reading and analyzing how the human body is performing to quickly and accurately diagnose conditions, starting with sleep. Using artificial intelligence, EnsoData’s technology analyzes millions of data points collected from sensors placed throughout the entire human body to deliver the most accurate diagnoses in an easy-to-read printout. Heartbeats on an EKG, eye movements through an EOG, and brain waves through an EEG all output as waveform data; EnsoData leads the world in reading and understanding waveforms. Learn more at ensodata.com.
